Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Aclasta 5 mg solution for infusion

Active Ingredient:
zoledronic acid monohydrate
Company:  
Sandoz Limited See contact details
ATC code: 
M05BA08
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Aclasta 5 mg solution for infusion - Patient Reminder Card

This Patient Reminder Card contains information regarding osteonecrosis of the jaw, a side effect that has been reported very rarely in patients receiving Aclasta. It also contains information regarding precautions that can be taken to reduce the risk of developing ONJ.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Sandoz Limited
Company image
Address
Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, UK
WWW
http://www.sandoz.uk.com
WWW
https://pvi1j.solutions.iqvia.com
Telephone
+44 (0) 1276 698020
Medical Information Direct Line
+44 (0)1276 698 101
Medical Information e-mail
[email protected]
Adverse event reporting email
[email protected]
Customer Care direct line
+44 (0)1276 698020
E-mail
[email protected]
E-mail
[email protected]